FDA clears antimicrobial blood pressure cuff:
This article was originally published in Clinica
Executive Summary
Vital Signs has received US FDA 510(k) clearance to market its antimicrobial-treated, single-patient-use blood pressure cuff. The Cuffable Plus device, which is impregnated with an antimicrobial agent, could help combat the cross contamination that leads to hospital-acquired infections, said the Totowa, New Jersey-based company. Noting that the US market for single-patient-use blood pressure cuffs is approaching $30 million, Vital said its antimicrobial enhancement would help it advance its number two market position.